• Round Table Discussion: How a Pivotal
Trial Could Usher in New Era of IL-2 Therapy
• HIF-2alpha: What Is the Impact of the
Nobel Prize-Winning Research?
• Targeted Therapy Following Immuno-
oncology Approaches in RCCa
• Circulating Tumor DNA in Advanced Renal
Cell Carcinoma – Is It Ready for Prime Time?
/kidneycancer.org
